As of 2025-11-18, the EV/EBITDA ratio of 4Basebio PLC (4BB.L) is -10.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4BB.L's latest enterprise value is 110.88 mil GBP. 4BB.L's TTM EBITDA according to its financial statements is -11.07 mil GBP. Dividing these 2 quantities gives us the above 4BB.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.9x - 15.6x | 14.9x |
| Forward P/E multiples | 14.2x - 21.6x | 17.8x |
| Fair Price | (861.33) - (946.97) | (998.22) |
| Upside | -220.9% - -232.9% | -240.1% |
| Date | EV/EBITDA |
| 2025-11-14 | -10.03 |
| 2025-11-13 | -10.03 |
| 2025-11-12 | -10.03 |
| 2025-11-11 | -10.15 |
| 2025-11-10 | -11.15 |
| 2025-11-07 | -11.15 |
| 2025-11-06 | -11.15 |
| 2025-11-05 | -11.15 |
| 2025-11-04 | -11.15 |
| 2025-11-03 | -11.15 |
| 2025-10-31 | -11.23 |
| 2025-10-30 | -11.22 |
| 2025-10-29 | -11.15 |
| 2025-10-28 | -11.15 |
| 2025-10-27 | -11.15 |
| 2025-10-24 | -10.22 |
| 2025-10-23 | -10.22 |
| 2025-10-22 | -10.22 |
| 2025-10-21 | -10.22 |
| 2025-10-20 | -10.22 |
| 2025-10-17 | -11.23 |
| 2025-10-16 | -10.76 |
| 2025-10-15 | -10.76 |
| 2025-10-14 | -10.76 |
| 2025-10-13 | -10.76 |
| 2025-10-10 | -10.76 |
| 2025-10-09 | -10.99 |
| 2025-10-08 | -10.99 |
| 2025-10-07 | -10.99 |
| 2025-10-06 | -10.99 |
| 2025-10-03 | -10.99 |
| 2025-10-02 | -10.99 |
| 2025-10-01 | -10.99 |
| 2025-09-30 | -11.30 |
| 2025-09-29 | -10.30 |
| 2025-09-26 | -10.22 |
| 2025-09-25 | -10.22 |
| 2025-09-24 | -10.22 |
| 2025-09-23 | -10.22 |
| 2025-09-22 | -10.15 |
| 2025-09-19 | -11.73 |
| 2025-09-18 | -11.88 |
| 2025-09-17 | -12.00 |
| 2025-09-16 | -12.00 |
| 2025-09-15 | -12.00 |
| 2025-09-12 | -12.00 |
| 2025-09-11 | -11.99 |
| 2025-09-10 | -12.23 |
| 2025-09-09 | -12.23 |
| 2025-09-08 | -12.23 |